News Overview

This has reference to the Board Meeting outcome filed on 04th November, 2022 intimating the declaration of 2nd Interim dividend of Rs. 8.50 per share. The record date for the same was fixed as 17th November 2022. We would like to inform that the payment of the dividend has been completed by credit to the eligible shareholders on 28th November 2022.

On 2 December 2022

On 3 December 2022

Biocon Biologics, subsidiary of Biocon announced today that it has successfully completed its multi-billion-dollar (USD) acquisition of the global biosimilars business of its partner Viatris Inc. (NASDAQ: VTRS). Biocon Biologics and Viatris have obtained all applicable approvals from key global regulators including the U.S. Federal Trade Commission, the Competition Commission of India and the Reserve Bank of India, and its investors. Effective from the date […]

Union Bank of India has allotted Unsecured, Subordinated, Non-Convertible, Taxable, Fully Paid-Up Basel III Compliant Tier- 2 Bonds in the nature of Debentures eligible for inclusion in Tier 2 Capital (Bonds) in two tranches of Rs.1500 crore (ISIN: INE692A08219,Series XXXVI-A) and Rs.700 crore (ISIN: INE692A08201,Series XXXVI-B) aggregating to Rs.2200 crore on 29 November 2022.Powered by Capital Market – Live News

Gland Pharma announced that it has through its wholly owned subsidiary Gland Pharma International, Singapore entered into a Put Option Agreement to acquire 100% of Cenexi Group for an Equity Value not exceeding Euro 120 Mn (Enterprise Value of Euro 230 Mn). Founded in 2004, Cenexi, along with its Subsidiaries, is engaged primarily in the business of Contract Development & Manufacturing Organisation (CDMO) of pharmaceutical […]

Record date is 10 December 2022

On 3 December 2022

On 6 December 2022

Wipro has granted 1,10,000 Restricted Stock units under Companys ADS Restricted Stock Unit Plan 2004 to its identified employees. This grant is effective from 28 November 2022. Powered by Capital Market – Live News